Respiratory Trends During Blood Transfusions in Newborns.

Recruiting N/A Interventional Study
Blood Transfusion Complication Blood Transfusion Associated Adverse Reactions Respiratory Complication Respiratory Morbidity
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
Up to 1 Month
Sex
Any
Study type
Interventional
Purpose
Diagnostic
Participants needed
71 (estimated)
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The prevalence of transfusion reactions is between 1 and 11% of transfusions. Most reactions are mild and do not pose a life-threatening risk to the patient. More serious problems may be the only manifestations that lead to suspicion of a transfusion reaction. Most noninfectious transfusion reactions are immune-mediated. Two main types of reactions can be distinguished: TACO (transfusion associat…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * admitted newborns requiring blood transfusions as per local practice and/or international guidelines Exclusion Criteria: * newborns with major malformations * need for palliative care * lack of informed consent
Contacts

Stefano Nobile, MD, PhD, MSc

+39 06 30151

stefano.nobile@policlinicogemelli.it

CONTACT

Stefano Nobile

stefano.nobile@policlinicogemelli.it

CONTACT